Latest news
Vertex Pharmaceuticals Rose 7% Today. Here’s Where the Stock Is Headed in 2026 - TIKR.comTIKR.com · Mon, 10 Aug 2026 21:05:29 GMTVertex's would-be rival Sionna scraps cystic fibrosis drug add-on after trial flop - FirstWord PHARMAFirstWord PHARMA · Mon, 10 Aug 2026 16:12:18 GMTWhy Vertex Pharmaceuticals Stock Ticked Higher on Tuesday - The Globe and MailThe Globe and Mail · Tue, 04 Aug 2026 21:57:00 GMTVertex Pharmaceuticals Inc. stock rises Tuesday, still underperforms market - MarketWatchMarketWatch · Tue, 04 Aug 2026 20:37:00 GMT[VRTX Q2 2026 Earnings Call] Vertex Lifts 2026 Guidance to $13.1B–$13.2B as CASGEVY Surges 150% and JOURNAVX Scales - finance.biggo.comfinance.biggo.com · Mon, 03 Aug 2026 22:55:00 GMTVertex Pharmaceuticals (NASDAQ:VRTX) Beats Q2 CY2026 Sales Expectations, Full-Year Outlook Slightly Exceeds Expectations - FinancialContentFinancialContent · Mon, 03 Aug 2026 20:36:00 GMTCRNX: Q2 2026 revenue rose to $25.1M on PALSONIFY launch; merger with Vertex expected in Q3 2026 - TradingViewTradingView · Mon, 03 Aug 2026 20:16:37 GMTVertex Q2 FY26 GAAP net income rises 6% to $1.1 billion; revenue increases 12% to $3.33 billion - BitgetBitget · Mon, 03 Aug 2026 07:00:00 GMT